364 related articles for article (PubMed ID: 8202159)
1. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin.
Kaushansky K; Lok S; Holly RD; Broudy VC; Lin N; Bailey MC; Forstrom JW; Buddle MM; Oort PJ; Hagen FS
Nature; 1994 Jun; 369(6481):568-71. PubMed ID: 8202159
[TBL] [Abstract][Full Text] [Related]
2. Thrombopoietin: the primary regulator of megakaryocyte and platelet production.
Kaushansky K
Thromb Haemost; 1995 Jul; 74(1):521-5. PubMed ID: 8578518
[TBL] [Abstract][Full Text] [Related]
3. Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit.
Broudy VC; Lin NL; Fox N; Taga T; Saito M; Kaushansky K
Blood; 1996 Sep; 88(6):2026-32. PubMed ID: 8822921
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow stromal cells produce thrombopoietin and stimulate megakaryocyte growth and maturation but suppress proplatelet formation.
Nagahisa H; Nagata Y; Ohnuki T; Osada M; Nagasawa T; Abe T; Todokoro K
Blood; 1996 Feb; 87(4):1309-16. PubMed ID: 8608219
[TBL] [Abstract][Full Text] [Related]
5. cMpl ligand is a humoral regulator of megakaryocytopoiesis.
Wendling F; Maraskovsky E; Debili N; Florindo C; Teepe M; Titeux M; Methia N; Breton-Gorius J; Cosman D; Vainchenker W
Nature; 1994 Jun; 369(6481):571-4. PubMed ID: 8202160
[TBL] [Abstract][Full Text] [Related]
6. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation.
Alexander WS; Roberts AW; Maurer AB; Nicola NA; Dunn AR; Metcalf D
Stem Cells; 1996; 14 Suppl 1():124-32. PubMed ID: 11012212
[TBL] [Abstract][Full Text] [Related]
7. The mpl ligand: molecular and cellular biology of the critical regulator of megakaryocyte development.
Kaushansky K
Stem Cells; 1994; 12 Suppl 1():91-6; discussion 96-7. PubMed ID: 7696972
[TBL] [Abstract][Full Text] [Related]
8. Thrombopoietin does not induce lineage-restricted commitment of Mpl-R expressing pluripotent progenitors but permits their complete erythroid and megakaryocytic differentiation.
Goncalves F; Lacout C; Villeval JL; Wendling F; Vainchenker W; Dumenil D
Blood; 1997 May; 89(10):3544-53. PubMed ID: 9160659
[TBL] [Abstract][Full Text] [Related]
9. c-mpl, the thrombopoietin receptor.
Vainchenker W; Methia N; Debili N; Titeux M; Wendling F
Thromb Haemost; 1995 Jul; 74(1):526-8. PubMed ID: 8578519
[TBL] [Abstract][Full Text] [Related]
10. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
Tong W; Lodish HF
J Exp Med; 2004 Sep; 200(5):569-80. PubMed ID: 15337790
[TBL] [Abstract][Full Text] [Related]
11. The residual megakaryocyte and platelet production in c-mpl-deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor.
Gainsford T; Nandurkar H; Metcalf D; Robb L; Begley CG; Alexander WS
Blood; 2000 Jan; 95(2):528-34. PubMed ID: 10627458
[TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin stimulates VEGF release from c-Mpl-expressing cell lines and haematopoietic progenitors.
Bobik R; Hong Y; Breier G; Martin JF; Erusalimsky JD
FEBS Lett; 1998 Feb; 423(1):10-4. PubMed ID: 9506832
[TBL] [Abstract][Full Text] [Related]
13. Thrombocytopenia in c-mpl-deficient mice.
Gurney AL; Carver-Moore K; de Sauvage FJ; Moore MW
Science; 1994 Sep; 265(5177):1445-7. PubMed ID: 8073287
[TBL] [Abstract][Full Text] [Related]
14. Effects of c-mpl ligand on cytoplasmic maturation of murine megakaryocytes and on platelet production.
Ishida Y; Ito T; Kuriya Si
J Histochem Cytochem; 1998 Jan; 46(1):49-57. PubMed ID: 9405494
[TBL] [Abstract][Full Text] [Related]
15. Cytokine production and function in c-mpl-deficient mice: no physiologic role for interleukin-3 in residual megakaryocyte and platelet production.
Gainsford T; Roberts AW; Kimura S; Metcalf D; Dranoff G; Mulligan RC; Begley CG; Robb L; Alexander WS
Blood; 1998 Apr; 91(8):2745-52. PubMed ID: 9531584
[TBL] [Abstract][Full Text] [Related]
16. Signaling by the Mpl receptor involves IKK and NF-kappaB.
Zhang Y; Sun S; Wang Z; Thompson A; Kaluzhny Y; Zimmet J; Ravid K
J Cell Biochem; 2002; 85(3):523-35. PubMed ID: 11967992
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Mpl mutants using primary megakaryocyte-lineage cells from mpl(-/-) mice: a new system for Mpl structure-function studies.
Gaur M; Murphy GJ; deSauvage FJ; Leavitt AD
Blood; 2001 Mar; 97(6):1653-61. PubMed ID: 11238104
[TBL] [Abstract][Full Text] [Related]
18. The relative population sizes of megakaryocytic cells in mouse bone marrow as determined by mpl ligand responsiveness.
Mintern J; Williams N; Jackson H
Exp Hematol; 1997 Nov; 25(12):1233-9. PubMed ID: 9357966
[TBL] [Abstract][Full Text] [Related]
19. Promegapoietin, a family of chimeric growth factors, supports megakaryocyte development through activation of IL-3 and c-Mpl ligand signaling pathways.
Doshi PD; Giri JG; Abegg AL; Favara JP; Huynh MS; Kahn LE; Minnerly JC; Pegg LE; Villani-Price D; Siegel NR; Staten NR; Thomas JW; McKearn JP; Smith WG
Exp Hematol; 2001 Oct; 29(10):1177-84. PubMed ID: 11602319
[TBL] [Abstract][Full Text] [Related]
20. Cloning and functional characterization of a novel c-mpl variant expressed in human CD34 cells and platelets.
Li J; Sabath DF; Kuter DJ
Cytokine; 2000 Jul; 12(7):835-44. PubMed ID: 10880227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]